Revvity Acquires ACD/Labs to Expand Revvity Signals Scientific Software Capabilities
November 10, 2025
Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software for analytical characterization and molecular design. The deal is expected to close in late Q4 2025 and will expand Revvity Signals by unifying analytical data with actionable scientific insights across the end-to-end scientific workflow.
- Buyers
- Revvity, Inc.
- Targets
- ACD/Labs
- Industry
- Cloud & SaaS
- Location
- Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Studio Science Acquires RevTech360
March 22, 2023
IT Services
Studio Science, a design and innovation consultancy backed by Inoca Capital Partners, has acquired RevTech360, a MuleSoft- and Salesforce-focused digital transformation and CRM consulting firm based in Indianapolis. The acquisition bolsters Studio Science’s Salesforce Commerce Cloud and cross-cloud integration capabilities and adds certified architects and developers to its enterprise offerings.
-
ATS Corporation Acquires Avidity Science
September 22, 2023
Medical Devices
ATS Corporation has entered into a definitive agreement to acquire Avidity Science, a designer and manufacturer of automated water purification and delivery systems for biomedical and life science applications, for US$195 million. The acquisition strengthens ATS's life sciences capabilities and is expected to close in Q4 2023 subject to customary regulatory filings.
-
Symmetry Laser Acquires ArcRev to Expand Precision Laser Cutting for Medical Devices
January 30, 2026
Medical Devices
Symmetry Laser has completed its acquisition of ArcRev, a specialized laser cutting company with a lean manufacturing culture. The deal expands Symmetry Laser’s technical capabilities and production capacity to better support medical device customers from rapid prototyping through high-volume production.
-
Novartis AG to Acquire Avidity Biosciences in $12B Deal (with Precision Cardiology SpinCo)
October 26, 2025
Biotechnology
Novartis AG has entered into a definitive merger agreement to acquire Avidity Biosciences for $72.00 per share in cash, valuing Avidity at approximately $12.0 billion. The transaction follows the planned separation of Avidity’s early-stage precision cardiology programs into a new publicly traded company (“SpinCo”), which is expected to begin trading after the spin-off.
-
Dotmatics Acquires Virscidian
September 25, 2024
Software
Dotmatics has acquired Virscidian, a provider of analytical chemistry solutions and automated chromatography and mass spectrometry data processing, to enhance its laboratory informatics and analytics capabilities. The deal expands Dotmatics' Luma Scientific Intelligence Platform with Virscidian's Analytical Studio, strengthening support for high-throughput experimental design and small-molecule R&D workflows.
-
VTG Acquires Next Rev Technologies, LLC
November 15, 2022
IT Services
VTG has acquired Next Rev Technologies, LLC to expand its multi-cloud software development, digital transformation, and cyber capabilities while adding Next Rev's U.S. Intelligence Community customers. The acquisition enhances VTG's data science and advanced analytics depth and supports its strategy to build a mid-tier national security company.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.